Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Bad
|
New words:
accessibility, Allied, amid, app, arose, Aviva, beck, bifurcated, biopharmaceutical, Birlasoft, blog, Bora, British, cannula, CCPA, center, centric, circulatory, color, compatibility, compose, composed, concept, contemporaneously, cyber, detachable, distance, eCommerce, elegant, Etude, Facebook, feet, Fla, fleet, formatted, German, greatly, HD, heart, height, highlighted, holder, hydroforming, IBR, implicit, Inline, Kite, Kuschall, lifting, LinkedIn, MDAP, MDD, media, merit, MHRA, modern, modernize, modernizing, MPS, NordBed, obey, ofIndustrial, outbreak, pandemic, portal, pound, prepaid, reassessed, Recompete, reliance, RememberMe, simple, sinking, SMOOV, sought, stage, stranded, successor, thoughtfully, thousand, today, transmit, Twitter, underwent, unplanned, UpFront, upholstery, Vaughn, worn, Wuhan, XBRL
Removed:
accelerating, accessory, accurate, addressed, aggregating, ahead, APB, assisted, challenge, closed, closure, compromise, connectivity, construction, coped, cycle, delayed, disparate, dissatisfaction, divested, divestiture, elderly, excise, executing, exempt, fastest, FSB, GCM, geographically, grown, hardware, importer, Instruction, interior, internet, knowledge, living, malware, Medsource, migrating, modality, narrow, nursing, older, opposite, pharmaceutical, Pinnacle, PMI, prepayment, proposed, rationalizing, redefined, renovation, rented, resolved, response, subordinated, theft, yield
Filing tables
Filing exhibits
Related press release
Associated IVCRQ transcripts
IVCRQ similar filings
Filing view
External links
Exhibit 10(aq)
Non-Employee Director Compensation | ||||||
Effective January 2020 | ||||||
Board Member Fees: | ||||||
Annual Retainer: | $ | 65,000 | ||||
Annual Equity Award: | $ | 130,000 | (1)(2) | |||
$ | 195,000 | |||||
Lead Director Fee: | $ | 20,000 | ||||
Committee Chair Fees: | ||||||
Audit | $ | 15,000 | ||||
Compensation | $ | 15,000 | ||||
Nominating & Governance | $ | 10,000 | ||||
Regulatory & Compliance | $ | 15,000 | ||||
Meeting Fees: | $ | 1,500 | (3) | |||
(1) | Target Value of restricted stock units | |||||
(2) | New Directors receive an award of a pro-rated number of shares of the most recent annual grant based on the months remaining until the next annual grant | |||||
(3) | For meetings attended in excess of 24 in a year | |||||